Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation, recognizes the financial hardships of cancer patients when paying for medications.
Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation, recognizes the financial hardships of cancer patients when paying for medications.
Transcript
Are you hearing from patients who read about new treatments that could cure them of their cancer, but who are facing barriers to getting access to this care?
We do. Patients will call us, and we do have a copayment assistance foundation, we do have funding for some types of cancers. We do hear from the patients when they call us and we don’t have a fund open for their type of cancer and they are very frustrated. "My doctor says this is what I need to take and I can’t get it." Or the co-pay is $4000. Sometimes they get misinformation, too. They don’t fully understand what their out of pocket is versus what the full cost of the drug is.
We do hear from patients, "This is great, I heard this medication can save my life, but I can’t get it." We will refer them to the drug company but even that, I guess, patients have to qualify for those programs. Medicare patients are not usually eligible for manufacturer sponsored programs. So, it does leave a lot of gaps in coverage for a lot of people.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More